Subcellular localization and expression pattern of the neurofibromatosis type 2 protein merlin/schwannomin

European Journal of Cell Biology

Volumn 72, Issue 1, 1997, Pages 46-53

  Schmucker, Beatrice ^a   Ballhausen, Wolfgang G ^a   Kressel, Michael ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Merlin; Moesin; Neurofibromatosis type 2; Schwannomin; Tumor suppressor gene

Indexed keywords

CYTOSKELETON PROTEIN; F ACTIN; LUBROL; MEMBRANE PROTEIN; MERLIN; MOESIN; PHALLOIDIN; POLYCLONAL ANTIBODY; RHODAMINE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL GROWTH; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; DISULFIDE BOND; DRUG SOLUBILITY; ENDOPLASMIC RETICULUM; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MOLECULAR WEIGHT; NEUROFIBROMATOSIS; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; TUMOR SUPPRESSOR GENE;

FALCO COLUMBARIUS;

EID: 0031019538     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Amieva, M. R., H. Furthmayr: Subcellular localization of moesin in dynamic filopodia, retraction libers, and other structures involved in substrate exploration, attachment, and cell-cell contacts. Exp. Cell Res. 219, 180-196 (1995).
2. Arakawa, H., N. Hayashi, H. Nagase, M. Ogawa, Y. Nakamura: Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Hum. Mol. Genet. 3, 565-568 (1994).
3. Avnur, Z., B. J. Geiger: Substrate-attached membranes of cultured cells, isolation and characterization of ventral cell membranes and the associated cytoskeleton. J. Mol. Biol. 153, 361-379 (1981).
4. Bianchi,:A. B., T. Hara, V. Ramesh, J. Gao, A. J. P. Klein-Szanto, F. Morin, A. G. Menon, J. A. Trofatter, J. F. Gusella, B. R. Seizinger N. Kley: Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumor types. Nature Genet. 6, 185-192 (1994).
5. Bretscher, A.: Rapid phosphorylation and reorganization of ezrin and spectrin accompany morphological changes induced in A-431 cells by epidermal growth factor. J. Cell Biol. 108, 921-930 (1989).
6. Claudio, J. O., M. Lutchman, G. A. Rouleau: Widespread but cell type-specific expression of the mouse neurofibromatosis type 2 gene. NeuroReport 6, 1942-1946 (1995).
7. Claudio, J. O., C. Marineau, G. A. Rouleau: The mouse homologue of the neurofibromatosis type 2 gene is highly conserved. Hum. Mol. Genet. 3, 185-190 (1994).
8. Den Bakker, M. A., P. H. J. Riegman, R. Arnold, C. P. Hekman, W. Boersma, P. J. A. Janssen, T. H. van der Kwast, E. C. Zwarthoff: The product of the NF2 tumour suppressor gene localizes near the plasma membrane and is highly expressed in muscle cells. Oncogene 10, 757-763 (1995).
9. Den Bakker, M. A., M. Tascilar, P. H. J. Riegman, A. C. P. Hekman, W. Boersma, P. J. A. Janssen, D. A. W. de Jong, W. Hendriks, T. H. van der Kwast, E. C. Zwarthoff: Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton. Am. J. Pathol. 147, 1339-1349 (1995).
10. Evans, D. G R., S. M. Huson, D. Donnai, W. Neary, V. Blair, V. Newton, T. Strachan, R. Harris: A genetic study of type 2 neuro-fibromatosis in the United Kingdom. II. Guidelines for genetic counseling. J. Med. Genet. 29, 847-852 (1992).
11. Franck, Z., R. Gary, A. Bretscher: Moesin, like ezrin, colocalizes with actin in the cortical cytoskeleton in cultured cells, but its expression is more variable. J. Cell Sci. 105, 219-231 (1993).
12. Friedman, S. J., C. L. Dewar, P. Skehan: Cytolocalization artifacts with immunofluorescent probes. Biochem. Cell Biol. 64, 1326-1332 (1986).
13. Gary, R., A. Bretscher: Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site. Mol. Biol. Cell 6, 1061-1075 (1995).
14. Gary, R., A. Bretscher: Heterotypic and homotypic associations between ezrin and moesin, two putative membrane-cytoskeletal link ing proteins. Proc. Natl. Acad. Sci. USA 90, 10846-10850 (1993).
15. Goldenthal, K. L., K. Hedman, J. W. Chen, J. T. August,. M. C. Willingham: Postfixation detergent treatment for immunofluirescence suppresses localization of some integral membrane proteins J. Histochem. Cytochem. 33, 813-820 (1985).
16. Gutmann, D. H., E. D. Wright, R. T. Geist, W. D. Snider: Expression of the neurofibromatosis 2 (NF2) gene isoforms during rat embryonic development. Hum. Mol. Genet. 4, 471-478 (1995).
17. Hedrick, L., K. R. Cho, B. Vogelstein: Cell adhesion molecules as tumor suppressors. Trends Cell Biol. 3, 36-39 (1993).
18. Henry, M. D., C. Gonzalez-Agosti, F. Solomon: Molecular dissection of radixin: distinct and interdependent functions of the amino-and carboxy-terminal domains. J. Cell Biol. 129, 1007-1022 (1995).
19. Kraus, C., J. Reina-Sanchez, Z. Sulekova, W. G. Ballhausen: Immunochemical identification of novel high-molecular-weight protein isoforms of the adenomatous polyposis coli (APC) gene. Int. J. Cancer. 65, 383-388 (1996).
20. Lankes, W., A. Griesmacher, J. Grünwald, R. Schwartz-Albiez R. Keller: A heparin-binding protein involved in inhibition of smooth muscle cell proliferation. Biochem. J. 251, 831-842 (1988).
21. Lous, D. N., V. Ramesh, J. F. Gusella: Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors. Brain Pathol. 5, 163-172 (1995).
22. Lutchman, M., G. A. Rouleau: The Neurofibromatosis type 2 gene product, Schwannomin, suppresses growth of NIH3T3 cells. Cancer Res. 55, 2270-2274 (1995).
23. Melan, M. A., G. Sluder: Redistribution and differential extraction of soluble proteins in permeabilized cultured cells. J. Cell Sci. 101, 731-743 (1992).
24. Moosic, J. P., E. Sung, A. Nilson, P. P. Jones, D. J. McKean: The selective solubilization of different murine splenocyte membrane fractions with Lubrol WX and Triton X-100 distinguishes two forms of Ia antigens. J. Biol. Chem. 257, 9684-9691 (1982).
25. Pakkanen, R., A. Vaheri: Cytovillin and other microvillar proteins of human choriocarcinoma cells. J. Cell. Biochem. 41, 1-12 (1989).
26. Pykett. M. J., M. Murphy, P. R. Harnish, D. L. George: The neurofibromatosis 2 (NF2) tumor suppressor gene encodes multiple alternatively spliced transcripts. Hum. Mol. Genet. 3, 559-564 (1994).
27. Rouleau, G. A., P. Merel, M. Lutchman, M. Sanson, J. Zucman, C. Marineau, K. Hoang-Xuan, S. Demczuk, C. Desmaze, B. Plougastel, S. M. Pulst, G. Lenoir, E. Bijlsma, R. Fashold, J. Dumanski, P. de Jong, D. Parry, R. Eldrige, A. Aurias, O. Delattre, G. Thomas: Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 363, 515-521 (1993).
28. Ruttledge, M. H., J. Sarrazin, S. Rangaratnam, C. M. Phelan, E. Twist, P. Merel, O. Delattre, G. Thomas, M. Nordenskjöld, V. P. Collins, J. P. Dumanski, G. A. Rouleau: Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nature Genet. 6, 180-184 (1994).
29. Sainz, J., D. P. Huynh, K. Figueroa, N. K. Ragge, M. E. Baser, S. M. Pulst; Mutations in the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum. Mol. Genet. 3, 885-891 (1994).
30. Sato, N., N. Funayama, A. Nagafuchi, S. Yoanemura, S. Tsukita, S. Tsukita: A gene family consisting of ezrin, radixin and moesin. J. Cell Sci. 103, 131-143 (1992).
31. Schwartz-Albiez, R., A. Merling, H. Spring, P. Möller, K. Koretz: Differential expression of the microspike-associated protein moesin in human tissues. Eur. J. Cell Biol. 67, 189-198 (1995).
32. Sekido, Y, H. I. Pass, S. Bader, D. J. Y. Mew, M. F. Christman, A. F. Gazdar, J. D. Minna: Neurofibromato sis type 2 gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res. 55, 1227-1231 (1995).
33. Takeshima, H., I. Izawa, P. S .Lee, N. Safdar, V. A. Levin, H. Saya: Detection of cellular proteins that interact with the NF2 tumor suppressor gene product. Oncogene 9, 2135-2144 (1994).
34. Takeuchi, K., N. Sato, H. Kasahara, N. Funayama, A. Nagafuchi, S. Yonemura, S. Tsukita, S. Tsukita: Perturbation of cell adhesion and microvilli formation by antisense oligonucieotides to ERM family members. J. Cell Biol. 125, 1371-1384 (1994).
35. Tikoo, A., M. Varga, V. Ramesh, J. Gusella, H. Maruta: An anti-Ras function of neurofibromatosis type 2 gene product (NF2/merlin). J. Biol. Chem. 269, 23387-23390 (1994).
36. Trofatter, J. A., M. M. MacCollin, J. L. Rutter, J. R. Murrell, M. P. Duyao, D. M. Parry, R. Eldridge, N. Kley, A G. Menon, K. Pulaski, V. H. Haase, C. M. Ambrose, D. Munroe, C. Bo ve, J. L. Haines, R. L. Martuza, M. E. MacDonald, B. R. Seizinger, M. P. Short, A. J. Buckler, J. F. Gusella: A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72, 791-800 (1993).
37. Tsukita, S., K. Oishi, N. Sato, J. Sagara, A. Kawai, S. Tsukita: ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol. 126, 391-401 (1994).
38. Tsukita, S., M. Itoh, A. Nagafuchi, S. Yonemura, S. Tsukita: Submembranous junctional plaque proteins include potential tumor suppressor molecules. J. Cell Biol. 123, 1049-1053 (1993).
39. Turunen, O., T. Wahlström, A. Vaheri: Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family. J. Cell Biol. 126, 1445-1453 (1994).
40. Twist, E. C., M. H. Ruttledge, M. Rousseau, M. Sanson, L. Papi, P. Merel, O. Delattre, G. Thomas, G. A. Rouleau: The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum. Mol. Genet. 3, 147-151 (1994).
41. Virtanen, I., P. Ekblom, P. Laurila: Subcellular compartmentalization of saccharide moieties in cultured normal and malignant cells. J. Cell Biol. 85, 429-434 (1980).
42. Wellenreuther, R., J. A. Kraus, D. Lenartz, A. G. Menon, I. Schramm, D. N. Louis, V. Ramesh, J. F. Gusella, O. D. Wiesther, A. von Deimling: Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am. J. Pathol. 146, 827-832 (1995).
43. Wu, D. Y., L. C. Wang, C. A. Mason, D. J. Goldberg: Association of β1 integrin with phosphotyrosine in growth cone filopodia. J. Neurosci. 16, 1470-1478 (1996).